BMRN: Message Board for BioMarin Pharmaceutical Inc. - InvestorVillage


BioMarin Pharmaceutical Inc.

  BMRN website

BMRN   /  Message Board

 
BOARD

GROUPS
 





 
Loading...
 
 
--




Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
MSG # SUBJECT TYPE AUTHOR SENTIMENT RECS DATE POSTED
130 BioMarin Announces Strong Second Quarter 2023 Results and Record Breaking Revenues fo GN jerrykrause 0 8/4/2023 12:39:14 PM
129 BioMarin's Roctavian becomes first FDA-approved gene therapy for severe haemophilia A GN jerrykrause 0 7/12/2023 6:50:10 PM
128 New $2.9 Million Gene Therapy Promises to Remake Hemophilia Treatment; BioMarin's gen GN jerrykrause 0 6/30/2023 2:34:24 AM
127 New Gene Therapy Could Face Uphill Battle; Potential FDA approval of BioMarin's gene GN jerrykrause 0 6/29/2023 12:00:32 PM
126 BioMarin Provides Update on FDA Review of ROCTAVIAN™ (Valoctocogene Roxaparvovec) Gen GN jerrykrause 0 3/8/2023 7:18:04 PM
125 BridgeBio Stock Surges on Positive Dwarfism Drug Data. It's Bad News for BioMarin. GN jerrykrause 0 3/6/2023 3:29:29 PM
124 With 2nd chance at FDA approval, BioMarin preps for hemophilia gene therapy launch in GN jerrykrause 0 3/4/2023 12:35:10 PM
123 FDA Decision Expected in Early 2023 on Hem A Gene Therapy Roctavian GN jerrykrause 0 10/15/2022 11:26:22 AM
122 First Gene Therapy for Adults with Severe Hemophilia A, BioMarin's ROCTAVIAN™ (valoct GN jerrykrause 1 8/26/2022 11:57:18 AM
121 BioMarin delays planned FDA filing for hemophilia gene therapy GN jerrykrause 1 6/2/2022 2:53:25 PM
Previous 111 Messages Top of Message List Post Message Go to Msg #  




Financial Market Data provided by
.
Loading...